NCT00979901View on ClinicalTrials.gov

Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,577

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

May 31, 2000

Study Completion Date

May 31, 2000

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

Comparator: montelukast

10 mg montelukast tablet given once daily at bedtime for 2 weeks

DRUG

Comparator: loratadine

10 mg loratadine tablet given once daily at bedtime for 2 weeks

DRUG

Comparator: placebo

placebo tablet given once daily at bedtime for 2 weeks

DRUG

Comparator: montelukast/loratadine

montelukast 10-mg/loratadine 10-mg combination tablet taken orally once daily at bedtime for 2 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00979901 - Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED) | Biotech Hunter | Biotech Hunter